Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (460)	1/4/2004 5:07:51 PM
From: Jibacoa	Respond to of 3722

Acccording to G.S.Burrill,CEO of Burrill & Co. of San Francisco,the biotech industry raised $16.3B in 2003 which was the second best year in biotech's financing history.<g> The FDA approved more than 19 biotech drugs in 2003 and with the passage of the $400B Medicare Prescription Drug on December 8, "biotech has a new Medicare partner," he also said that under the leadership of Commissioner Mark McClellan there is already some acceleration of the drug approval process. Among Biotech movers he mentioned are NGEN,CRGN, MLNM, XOMA,PDLI,TKTX,AMGN,ELN,CERS,ZGEN,ESPR,NRGN,VLGC and CPHD nachrichten.boerse.de Bernard

To: Jibacoa who wrote (460)	1/6/2004 10:27:04 AM
From: tuck	Read Replies (1) \| Respond to of 3722

What's your current take on NGEN, Bernard? Nice call, BTW. TIA & Cheers, Tuck

To: Jibacoa who wrote (460)	1/27/2004 4:16:45 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

NGEN Made a new H at 2.15PM when it traded at 14.10 The stock closed at 13.32 up 14.72% for the day. The volume today increased to more than 13.47M which is almost 4x its daily average, but below the volume of 23.946M on December 29 or the 29.291M on December 3,which was the day the present UPTREND started.<g> On January 5, the day of its previous H, the volume was 13.786M, which is comparable to today's.<g> There are no new news,(that I am aware ) since they announced the deal with TBIO on January 15. bigcharts.marketwatch.com From a longer term perspective (and with help of some short covering <g>) the stock still has some room to run. bigcharts.marketwatch.com Bernard